These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24014143)

  • 1. Effect of food on the pharmacokinetics of lurasidone: results of two randomized, open-label, crossover studies.
    Preskorn S; Ereshefsky L; Chiu YY; Poola N; Loebel A
    Hum Psychopharmacol; 2013 Sep; 28(5):495-505. PubMed ID: 24014143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of food intake on the pharmacokinetic properties of mirabegron oral controlled-absorption system: a single-dose, randomized, crossover study in healthy adults.
    Lee J; Zhang W; Moy S; Kowalski D; Kerbusch V; van Gelderen M; Sawamoto T; Grunenberg N; Keirns J
    Clin Ther; 2013 Mar; 35(3):333-41. PubMed ID: 23497763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of calories and fat content of meals on oral ziprasidone absorption: a randomized, open-label, crossover trial.
    Gandelman K; Alderman JA; Glue P; Lombardo I; LaBadie RR; Versavel M; Preskorn SH
    J Clin Psychiatry; 2009 Jan; 70(1):58-62. PubMed ID: 19026256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How sequential studies inform drug development: evaluating the effect of food intake on optimal bioavailability of ziprasidone.
    Lincoln J; Stewart ME; Preskorn SH
    J Psychiatr Pract; 2010 Mar; 16(2):103-14. PubMed ID: 20511734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the effects of formulation and food on the pharmacokinetics of lenvatinib (E7080) in healthy volunteers.
    Shumaker R; Aluri J; Fan J; Martinez G; Ren M; Chen K
    Int J Clin Pharmacol Ther; 2014 Apr; 52(4):284-91. PubMed ID: 24548978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, phase I, 3-way crossover study to examine the effects of food on the pharmacokinetics of single doses of 400 mg posaconazole oral suspension in healthy male Taiwanese subjects.
    Lin TY; Yang MH; Chang FY
    Ther Drug Monit; 2013 Apr; 35(2):223-7. PubMed ID: 23503449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of food on the absorption of oral ziprasidone.
    Miceli JJ; Glue P; Alderman J; Wilner K
    Psychopharmacol Bull; 2007; 40(3):58-68. PubMed ID: 18007569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of food intake on the pharmacokinetic properties of dalcetrapib: findings from three phase I, single-dose crossover studies in healthy volunteers.
    Derks M; Kawamura H; Abt M; Meneses-Lorente G; Phelan M; Ishikawa T
    Clin Ther; 2011 Jun; 33(6):754-65. PubMed ID: 21704240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of cinacalcet are unaffected following consumption of high- and low-fat meals.
    Padhi D; Salfi M; Harris RZ
    Am J Ther; 2007; 14(3):235-40. PubMed ID: 17515696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of different meal compositions on the oral bioavailability of treprostinil diolamine in healthy volunteers.
    Lim A; Wang-Smith L; Kates J; Laurent A; Kumar P; Laliberte K
    J Clin Pharm Ther; 2013 Dec; 38(6):450-5. PubMed ID: 23927483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of meal and antisecretory agents on the pharmacokinetics of danoprevir/ritonavir in healthy volunteers.
    Morcos PN; Moreira SA; Navarro MT; Bech N; Quatkemeyer A; Smith PF; Brennan BJ
    J Pharm Pharmacol; 2014 Jan; 66(1):23-31. PubMed ID: 24117531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of food on the oral bioavailability of didanosine from encapsulated enteric-coated beads.
    Damle BD; Yan JH; Behr D; O'Mara E; Nichola P; Kaul S; Knupp C
    J Clin Pharmacol; 2002 Apr; 42(4):419-27. PubMed ID: 11936567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of different meal compositions and fasted state on the oral bioavailability of etravirine.
    Schöller-Gyüre M; Boffito M; Pozniak AL; Leemans R; Kakuda TN; Woodfall B; Vyncke V; Peeters M; Vandermeulen K; Hoetelmans RM
    Pharmacotherapy; 2008 Oct; 28(10):1215-22. PubMed ID: 18823217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of food on the pharmacokinetics of ponatinib in healthy subjects.
    Narasimhan NI; Dorer DJ; Niland K; Haluska F; Sonnichsen D
    J Clin Pharm Ther; 2013 Dec; 38(6):440-4. PubMed ID: 23888935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychotic.
    Citrome L
    Int J Clin Pract; 2011 Feb; 65(2):189-210. PubMed ID: 21129135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I study of the pharmacokinetic and safety profiles of oral pazopanib with a high-fat or low-fat meal in patients with advanced solid tumors.
    Heath EI; Chiorean EG; Sweeney CJ; Hodge JP; Lager JJ; Forman K; Malburg L; Arumugham T; Dar MM; Suttle AB; Gainer SD; LoRusso P
    Clin Pharmacol Ther; 2010 Dec; 88(6):818-23. PubMed ID: 20980999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral bioavailability of ospemifene improves with food intake.
    Koskimies P; Katila K; Lammintausta R; Aaltonen AM; Vuorinen J; Saarni O; Scheinin M
    Int J Clin Pharmacol Ther; 2013 Oct; 51(10):787-94. PubMed ID: 24040848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the effect of food on the pharmacokinetics of axitinib in healthy volunteers.
    Pithavala YK; Chen Y; Toh M; Selaru P; LaBadie RR; Garrett M; Hee B; Mount J; Ni G; Klamerus KJ; Tortorici MA
    Cancer Chemother Pharmacol; 2012 Jul; 70(1):103-12. PubMed ID: 22644797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of food and the proton pump inhibitor rabeprazole on the pharmacokinetics of GDC-0941 in healthy volunteers: bench to bedside investigation of pH-dependent solubility.
    Ware JA; Dalziel G; Jin JY; Pellett JD; Smelick GS; West DA; Salphati L; Ding X; Sutton R; Fridyland J; Dresser MJ; Morrisson G; Holden SN
    Mol Pharm; 2013 Nov; 10(11):4074-81. PubMed ID: 24099279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of food with varying fat content on the clinical pharmacokinetics of gabapentin after oral administration of gabapentin enacarbil.
    Lal R; Sukbuntherng J; Luo W; Huff FJ; Zou J; Cundy KC
    Int J Clin Pharmacol Ther; 2010 Feb; 48(2):120-8. PubMed ID: 20137764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.